Tuesday, 11 May 2021, 4:34 pm Medical professionals and groups are sounding growing international concern around the use of puberty blockers to treat young people with gender dysphoria because of the low certainty of benefits, but the significant potential for medical harm. Family First is calling on the New Zealand government to pause the use of puberty blockers for teenagers while further research is undertaken, a sentiment supported by a majority of New Zealanders. Sweden’s leading gender clinic - Stockholm’s Astrid Lindgren children’s hospital - has become the world’s first to end routine treatment of minors under the age of 18 with